Search research articles
Contact Us
Filters
Showing results (71-80 of 92) with videos related to
Page
of 10
Sort By:
Bioconjugate Chemistry
|
May 29, 2019
Synthesis of the New Cyanine-Labeled Bacterial Lipooligosaccharides for Intracellular Imaging and in Vitro Microscopy Studies
Tung-Cheng Wang, Florent Cochet, Fabio Alessandro Facchini, et al.
Cell Death & Disease
|
February 17, 2018
Toll-like receptor 4 modulation influences human neural stem cell proliferation and differentiation
Chiara Grasselli, Daniela Ferrari, Cristina Zalfa, et al.
Innate Immunity
|
March 4, 2025
Preclinical development of the TLR4 antagonist FP12 as a drug lead targeting the HMGB1/MD-2/TLR4 axis in lethal influenza infection
Kari Ann Shirey, Alessio Romerio, Mohammed Monsoor Shaik, et al.
Scientific Reports
|
January 21, 2017
TLR4 antagonist FP7 inhibits LPS-induced cytokine production and glycolytic reprogramming in dendritic cells, and protects mice from lethal influenza infection
Laure Perrin-Cocon, Anne Aublin-Gex, Stefania E Sestito, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
September 24, 2022
Istaroxime Metabolite PST3093 Selectively Stimulates SERCA2a and Reverses Disease-Induced Changes in Cardiac Function
Martina Arici, Mara Ferrandi, Paolo Barassi, et al.
Chembiochem : a European Journal of Chemical Biology
|
December 17, 2013
Modulation of CD14 and TLR4·MD-2 activities by a synthetic lipid A mimetic
Roberto Cighetti, Carlotta Ciaramelli, Stefania Enza Sestito, et al.
Scientific Reports
|
January 31, 2019
Novel carboxylate-based glycolipids: TLR4 antagonism, MD-2 binding and self-assembly properties
Florent Cochet, Fabio A Facchini, Lenny Zaffaroni, et al.
Journal of Medicinal Chemistry
|
March 21, 2024
Novel TLR4-Activating Vaccine Adjuvant Enhances the Production of <i>Enterococcus faecium</i>-binding Antibodies
Ana Rita Franco, Océane Sadones, Alessio Romerio, et al.
Journal of Translational Medicine
|
January 19, 2024
Selective SERCA2a activator as a candidate for chronic heart failure therapy
Martina Arici, Shih-Che Hsu, Mara Ferrandi, et al.
Chemmedchem
|
February 20, 2009
Design, synthesis, and biological evaluation of levoglucosenone-derived ras activation inhibitors
Christian Müller, Maria Antonia Gomez-Zurita Frau, Dario Ballinari, et al.
Page
of 10
Search research articles
Search
Showing results (71-80 of 92) with videos related to
Sort By:
Page
of 10
Bioconjugate Chemistry
|
May 29, 2019
Synthesis of the New Cyanine-Labeled Bacterial Lipooligosaccharides for Intracellular Imaging and in Vitro Microscopy Studies
Tung-Cheng Wang, Florent Cochet, Fabio Alessandro Facchini, et al.
Cell Death & Disease
|
February 17, 2018
Toll-like receptor 4 modulation influences human neural stem cell proliferation and differentiation
Chiara Grasselli, Daniela Ferrari, Cristina Zalfa, et al.
Innate Immunity
|
March 4, 2025
Preclinical development of the TLR4 antagonist FP12 as a drug lead targeting the HMGB1/MD-2/TLR4 axis in lethal influenza infection
Kari Ann Shirey, Alessio Romerio, Mohammed Monsoor Shaik, et al.
Scientific Reports
|
January 21, 2017
TLR4 antagonist FP7 inhibits LPS-induced cytokine production and glycolytic reprogramming in dendritic cells, and protects mice from lethal influenza infection
Laure Perrin-Cocon, Anne Aublin-Gex, Stefania E Sestito, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
September 24, 2022
Istaroxime Metabolite PST3093 Selectively Stimulates SERCA2a and Reverses Disease-Induced Changes in Cardiac Function
Martina Arici, Mara Ferrandi, Paolo Barassi, et al.
Chembiochem : a European Journal of Chemical Biology
|
December 17, 2013
Modulation of CD14 and TLR4·MD-2 activities by a synthetic lipid A mimetic
Roberto Cighetti, Carlotta Ciaramelli, Stefania Enza Sestito, et al.
Scientific Reports
|
January 31, 2019
Novel carboxylate-based glycolipids: TLR4 antagonism, MD-2 binding and self-assembly properties
Florent Cochet, Fabio A Facchini, Lenny Zaffaroni, et al.
Journal of Medicinal Chemistry
|
March 21, 2024
Novel TLR4-Activating Vaccine Adjuvant Enhances the Production of <i>Enterococcus faecium</i>-binding Antibodies
Ana Rita Franco, Océane Sadones, Alessio Romerio, et al.
Journal of Translational Medicine
|
January 19, 2024
Selective SERCA2a activator as a candidate for chronic heart failure therapy
Martina Arici, Shih-Che Hsu, Mara Ferrandi, et al.
Chemmedchem
|
February 20, 2009
Design, synthesis, and biological evaluation of levoglucosenone-derived ras activation inhibitors
Christian Müller, Maria Antonia Gomez-Zurita Frau, Dario Ballinari, et al.
Page
of 10